Cardiovascular Drugs Market Global Briefing 2022: Ukraine-Russia War Impact
Report Highlights
Including: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Angina Pectoris; Congestive Heart Failure; Other Drugs For Cardiovascular Diseases (Anti-Arrhythmic And Anti-Anginal Drugs)
Global cardiovascular drugs market was worth $146.2 billion in 2021, it was the fourth largest segment within the market accounting for 10.0%. In terms of per capita consumption, the market was $19.1 and in terms of global GDP, the market was 0.16%. Cardiovascular drugs was the fourth largest segment within the market accounting for 10.0% preceded and followed by central nervous system drugs at 11.6% and respiratory diseases drugs at 9.8% respectively.
Cardiovascular Drugs Market Global Briefing 2022: Ukraine-Russia War Impact provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs sector.
Reasons to Purchase
- Fully updated for 2022 with Ukraine-Russia War Impact.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Description
Cardiovascular Drugs Market Global Briefing 2022: Ukraine-Russia War Impact from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the cardiovascular drugs market revenues, covering both the historic growth of the market and forecasting the future.
- Market segmentations break down the key sub sectors which make up the market.
- The regional breakdowns section gives the size of the market geographically.
- The trends and strategies section highlights the likely future developments in the cardiovascular drugs market and suggests approaches.
Scope
Markets Covered: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Angina Pectoris; Congestive Heart Failure; Other Drugs For Cardiovascular Diseases (Anti-Arrhythmic And Anti-Anginal Drugs)
Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa
Time series: Five years historic and forecast
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : Global Cardiovascular Drugs Market, Historic Market Size, 2016-2021, $
- Table 2 : Global Cardiovascular Drugs Market, Forecast Market Size, 2021-2026, $
- Table 3 : Global Cardiovascular Drugs Market, Split By Segment, 2021, $
- Table 4 : Global Cardiovascular Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
- Table 5 : Global Cardiovascular Drugs Market, Split By Region, 2021, $
- Table 6 : Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026
- Table 7 : Cardiovascular Drugs Market Data Sources
- Figure 1 : Global Cardiovascular Drugs Market, Historic Market Size, 2016-2021, $
- Figure 2 : Global Cardiovascular Drugs Market, Forecast Market Size, 2021-2026, $
- Figure 3 : Global Cardiovascular Drugs Market, Split By Segment, 2021, $
- Figure 4 : Global Cardiovascular Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
- Figure 5 : Global Cardiovascular Drugs Market, Split By Region, 2021, $
- Figure 6 : Global Cardiovascular Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Cardiovascular Drugs Global Market Competitor Briefing 2021
Including: Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs); Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics
Covering: Bristol-Myers Squibb; Sanofi S.A; Johnson & Johnson; Novartis AG; Bayer AG
Bristol-Myers Squibb was the largest competitor with 10.45% of the market followed by Sanofi S.A and Johnson & Johnson
Cardiovascular Drugs Global Market Competitor Briefing 2021 provides strategists, marketers and ...
Cardiovascular Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery
Including: Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs); Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics
Covering: Medtronic Inc.; Boston Scientific Corporation; Abbott Laboratories; Edwards Lifesciences; Cardinal Health, Inc.
Medtronic Inc. was the largest competitor with 18.22% of the market followed by Boston Scientific Corporation and Abbott Laboratories.
Cardiovascular Drugs Investment Competitor Outlook 2020: Covid 19 ...
Cardiovascular Drugs Market Global Briefing 2020: Covid 19 Impact and Recovery
Including: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)
Cardiovascular Drugs Market Competitor Briefing 2019
Including: Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)
Covering: Bristol-Myers Squibb; Sanofi S.A.; Johnson & Johnson; Astrazeneca; Novartis AG
Research Methodology
The report is built on information collected through secondary sources and analysis done by The Business Research
Company (TBRC). The secondary sources include the data published by statistical bodies, ...
Cardiovascular Drugs Market Global Briefing 2017
Research Methodology
The report is built on information collected through secondary sources and analysis done by The Business Research Company (TBRC). The secondary sources include the data published by statistical bodies, government agencies, market intelligence databases and annual reports. Insights on the current market scenario, historic and forecast market drivers were gathered from industry reports and news articles.
Note on ...
Cardiovascular Drugs Market Global Briefing 2018
Including: Cardiovascular Drugs, Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases.
Covering: Merck & Co., Sanofi S.A., Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly And Company, Johnson & Johnson, AstraZeneca Plc., Abbott Laboratories Inc., Bayer AG
Research Methodology
The Business Research Company’s reports are based on the methodology below.
Data –
Our datasets are created using ...
Cardiovascular Drugs Market Global Briefing 2017
Including: Anti-hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases.
Covering: Merck & Co., Sanofi, Pfizer, Bristol-Myers Squibb Company, Novartis AG, Eli Lilly, Johnson & Johnson, AstraZeneca PLC, Abbott Laboratories Inc., Bayer AG
Research Methodology
The Business Research Company’s reports are based on the methodology below.
Data
Our datasets are created using a wide range ...